capecitabine,temozolomide
roche
['e2211', '4004']
interesting presentation by discussing the results of the largest mgmt study #e2211 at #asco2022. the data indicates a promising combination of #capecitabine/temozolomide for the treatment of #pnets and as a comparator arm in further clinical trials. abs4004 #meded
Independent and international experts in the field of neuroendocrine tumors (NET). Part of https://t.co/09VX0euMEA